PreView: The Preventive Video Education in Waiting Rooms Program

NCT02264782 | Completed

• 3 other identifiers: 14988NCI-2017-00456R01CA158027
• Study Type: interventional
• Target: 508
• Locations: 1 country
• Sites: 2

Brief Summary

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Conditions

Health Status Unknown

Outcome Measures

Primary Outcomes (3)

• Changing participants' readiness to be screened for breast, cervical and colorectal cancer

  To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care

  Up to 3 hours from pre-visit to post-visit interview.

• Increasing physician-patient discussions about PSA screening measured by chart review

  To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.

  Baseline up to 14 months

• Increasing rates of breast, cervical and colorectal cancer screening

  To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

  From Baseline up to 14 months

Study Arms (2)

Group I (PreView)

EXPERIMENTAL

Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

Other: Computer-Assisted Intervention; Other: Questionnaire Administration

Group II (educational video)

ACTIVE COMPARATOR

Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Other: Computer-Assisted Intervention; Other: Questionnaire Administration

Interventions

Computer-Assisted Intervention OTHER

Complete PreView

Group I (PreView)

Questionnaire Administration OTHER

Ancillary studies

Group I (PreView); Group II (educational video)

Eligibility Criteria

• Age: 50 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Without a history of cancer

You may not qualify if:

• With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
• Individuals who do not speak English or Spanish (except for the testimonials)

Sponsors & Collaborators

• University of California, San Francisco: lead
• National Cancer Institute (NCI): collaborator

Study Sites (2)

John Muir Medical Center-Concord Campus

Concord, California, 94520, United States

Location

UCSF Medical Center-Mount Zion

San Francisco, California, 94115, United States

Location

Related Publications (1)

• Walsh J, Potter M, Salazar R, Ozer E, Gildengorin G, Dass N, Green L. PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening. J Gen Intern Med. 2020 Feb;35(2):449-456. doi: 10.1007/s11606-019-05438-0. Epub 2019 Nov 14.

  PMID: 31728894 DERIVED

Study Officials

• Judith Walsh

  UCSF Medical Center-Mount Zion

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 6, 2014
• First Posted: October 15, 2014
• Study Start: July 1, 2013
• Primary Completion: February 1, 2019
• Study Completion: March 1, 2019
• Last Updated: July 22, 2020

Record last verified: 2020-07

Locations

US (2)